Tempero Bio co-founder Joe Jimenez (L) and president and CSO Ricardo Dolmetsch
Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders
A small Oakland, CA-based biotech hoping to take on the sprawling landscape of substance use disorders and addiction has reeled in $70 million.
The drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
